Playing Volatility: Making a 2020-Averse Portfolio
In this case we normalize the ratio between SPY and FDLO (one of the better-performing min-volatility etfs of the year) to the start of the year. We can clearly see a shift in favour of a min-volatility portfolio as of late.
Performing efficient frontier upon FDLO to narrow down our investments, we see that, for maximizing a Sharpe ratio at the current 3-month treasury bond yield, our best options are (in terms of TICKER, WEIGHT):
CI,0.20459
LIN,0.14878
CABO,0.01408
CTXS,0.01166
CLX,0.01038
AKAM,0.00986
DPZ,0.00929
DG,0.00923
ADBE,0.00918
INTU,0.00909
and so on.
stats: Expected annual return: 22.8%
Annual volatility: 10.9%
Sharpe Ratio: 1.90
Minimizing volatility as opposed to maximizing Sharpe gives us more tickers (of course, the portfolio was made to be volatility-averse in general... but not COVID-Recession-Averse).
For stats of
Expected annual return: 14.1%
Annual volatility: 8.5%
Sharpe Ratio: 1.42,
We see:
LIN,0.04622
EQC,0.04516
DPZ,0.03391
CLX,0.03318
VZ,0.03257
WMT,0.03243
CHRW,0.02722
CI,0.02714
CABO,0.02352
DOX,0.02221
CHKP,0.02112
And so on...
Performing efficient frontier upon FDLO to narrow down our investments, we see that, for maximizing a Sharpe ratio at the current 3-month treasury bond yield, our best options are (in terms of TICKER, WEIGHT):
CI,0.20459
LIN,0.14878
CABO,0.01408
CTXS,0.01166
CLX,0.01038
AKAM,0.00986
DPZ,0.00929
DG,0.00923
ADBE,0.00918
INTU,0.00909
and so on.
stats: Expected annual return: 22.8%
Annual volatility: 10.9%
Sharpe Ratio: 1.90
Minimizing volatility as opposed to maximizing Sharpe gives us more tickers (of course, the portfolio was made to be volatility-averse in general... but not COVID-Recession-Averse).
For stats of
Expected annual return: 14.1%
Annual volatility: 8.5%
Sharpe Ratio: 1.42,
We see:
LIN,0.04622
EQC,0.04516
DPZ,0.03391
CLX,0.03318
VZ,0.03257
WMT,0.03243
CHRW,0.02722
CI,0.02714
CABO,0.02352
DOX,0.02221
CHKP,0.02112
And so on...
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.